Novartis bolsters Neuroscience pipeline with in-licensing of PTC518 for Huntington’s disease
imberje1
Mon, 12/02/2024 – 11:05
Read more about Novartis bolsters Neuroscience pipeline with in-licensing of PTC518 for Huntington’s disease
PrintPDF
Entries by imberje1
Novartis implements manufacturing adjustments for ribociclib to ensure alignment with latest regulatory standards in eBC by end of Q2
imberje1
Tue, 04/09/2024 – 20:37
Read more about Novartis implements manufacturing adjustments for ribociclib to …
Novartis implements manufacturing adjustments for ribociclib to ensure alignment with latest regulatory standards in eBC by end of Q2
imberje1
Tue, 04/09/2024 – 20:37
Read more about Novartis implements manufacturing adjustments for ribociclib to …
Novartis confirms plans to file for Pluvicto® pre-taxane label expansion in H2 2024 based on latest data from Phase III PSMAfore study
imberje1
Wed, 04/03/2024 – 14:36
Read more about Novartis confirms plans to file for Pluvicto® pre-taxane label …
Novartis shares strategy and growth update at J.P. Morgan Healthcare Conference 2024
imberje1
Mon, 01/08/2024 – 16:32
Read more about Novartis shares strategy and growth update at J.P. Morgan Healthcare Conference 2024
PrintPDF